Skip to content

Methanthelinium

ALIMENTARY TRACT AND METABOLISM

Also known as: banthine, methanthelin, methantheline, methantheline bromide, methanthelinium bromide

OfmFDA approvedATC A03AB07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Methanthelinium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1951. DrugCentral lists 1 molecular target, including CHRM2|CHRM4|CHRM5|CHRM1|CHRM3. Recorded indications include Gastric ulcer, Peptic ulcer and Urinary incontinence.

  • Approval status: ofm (first approved 1951 by the FDA).
  • Molecular targets: CHRM2|CHRM4|CHRM5|CHRM1|CHRM3 (1 listed in DrugCentral).
  • Indications: Gastric ulcer, Peptic ulcer and Urinary incontinence.
  • ATC code: A03AB07 (Synthetic anticholinergics, quaternary ammonium compounds).
  • Molecular formula: C21H26NO3; molecular weight 340.44 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Gastric ulcer
  • Peptic ulcer
  • Urinary incontinence

Off-label uses (1)

  • Irritable bowel syndrome

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Muscarinic acetylcholine receptorCHRM2|CHRM4|CHRM5|CHRM1|CHRM3antagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1951-07-03FDA—SHIRE

ATC classification

ATC codeTherapeutic hierarchy
A03AB07ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › Synthetic anticholinergics, quaternary ammonium compounds

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Methanthelinium is on its molecule page.

Molecular formulaC21H26NO3
Molecular weight340.44 g/mol
CAS number5818-17-7
InChIKeyGZHFODJQISUKAY-UHFFFAOYSA-N
PubChem CID4097
CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Methanthelinium used for?

DrugCentral lists the following indications for Methanthelinium: Gastric ulcer, Peptic ulcer and Urinary incontinence.

How does Methanthelinium work?

Its molecular targets in DrugCentral include CHRM2|CHRM4|CHRM5|CHRM1|CHRM3 (antagonist).

When was Methanthelinium first approved?

Methanthelinium was first approved by the FDA in 1951.

What is the chemical formula of Methanthelinium?

Methanthelinium has the molecular formula C21H26NO3 and a molecular weight of 340.44 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1951-07-03
AgencyFDA
Targets1
Indications3
FormulaC21H26NO3
DrugCentral ID1736
Interactive profile